Get the Stockscreener App
5.42
4.83%
-0.275
Chromadex Corp stock is traded at $5.42, with a volume of 438.19K.
It is down -4.83% in the last 24 hours and down -11.00% over the past month.
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.
See More
Previous Close:
$5.695
Open:
$5.78
24h Volume:
438.19K
Relative Volume:
0.83
Market Cap:
$409.42M
Revenue:
$83.57M
Net Income/Loss:
$-4.94M
P/E Ratio:
-77.43
EPS:
-0.07
Net Cash Flow:
$6.97M
1W Performance:
-7.67%
1M Performance:
-11.00%
6M Performance:
+57.33%
1Y Performance:
+256.58%
1-Day Range:
$5.41
$5.80
1-Week Range:
$5.41
$6.06
52-Week Range:
$1.48
$7.9738
Chromadex Corp Stock (CDXC) Company Profile
Name
Chromadex Corp
Sector
Industry
Phone
310-388-6706
Address
10900 WILSHIRE BLVD, LOS ANGELES
Compare CDXC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDXC
Chromadex Corp
|
5.42 | 409.42M | 83.57M | -4.94M | 6.97M | -0.07 |
|
KHC
Kraft Heinz Co
|
31.13 | 37.80B | 25.85B | 2.74B | 3.02B | 2.26 |
|
GIS
General Mills Inc
|
61.00 | 33.63B | 19.90B | 2.60B | 2.80B | 4.60 |
|
K
Kellanova
|
82.66 | 28.11B | 12.80B | 1.01B | 927.00M | 2.91 |
|
MKC
Mccormick Co Inc
|
80.14 | 21.49B | 6.68B | 792.60M | 774.40M | 2.94 |
|
HRL
Hormel Foods Corp
|
29.65 | 16.28B | 11.92B | 805.04M | 1.01B | 1.46 |
Chromadex Corp Stock (CDXC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-16-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Aug-11-22 | Downgrade | B. Riley Securities | Buy → Neutral |
| Mar-08-22 | Initiated | ROTH Capital | Buy |
| Oct-16-19 | Initiated | Oppenheimer | Outperform |
| Feb-14-19 | Initiated | B. Riley FBR | Buy |
| Nov-27-17 | Resumed | H.C. Wainwright | Buy |
| Sep-25-17 | Initiated | Ladenburg Thalmann | Buy |
| Jan-03-17 | Initiated | Rodman & Renshaw | Buy |
View All
Chromadex Corp Stock (CDXC) Latest News
ChromaDex And 2 Other Undervalued Small Caps In US With Insider Buying - Yahoo Canada Finance
ChromaDex Co. (NASDAQ:CDXC) Short Interest Update - MarketBeat
Should Weakness in ChromaDex Corporation's (NASDAQ:CDXC) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? - Yahoo Canada Finance
SG Americas Securities LLC Buys 7,117 Shares of ChromaDex Co. (NASDAQ:CDXC) - Defense World
Sargent Investment Group LLC Invests $263,000 in ChromaDex Co. (NASDAQ:CDXC) - MarketBeat
ChromaDex Co. (NASDAQ:CDXC) Short Interest Up 6.7% in January - MarketBeat
Chromadex Corp : Wired News – ChromaDex Launched TRU NIAGEN(TM) in Singapore with Retail Partner Watsons - Marketscreener.com
JPMorgan Chase & Co. Buys 33,150 Shares of ChromaDex Co. (NASDAQ:CDXC) - Defense World
Barclays PLC Grows Stock Position in ChromaDex Co. (NASDAQ:CDXC) - Defense World
ChromaDex Co. (NASDAQ:CDXC) Short Interest Up 6.7% in December - Defense World
Short Interest in ChromaDex Co. (NASDAQ:CDXC) Grows By 6.7% - MarketBeat
StockNews.com Downgrades ChromaDex (NASDAQ:CDXC) to Buy - MarketBeat
ChromaDex (NASDAQ:CDXC) Rating Lowered to “Buy” at StockNews.com - Defense World
Jane Street Group LLC Has $167,000 Position in ChromaDex Co. (NASDAQ:CDXC) - Defense World
ChromaDex (NASDAQ:CDXC) Share Price Crosses Above 200-Day Moving Average – Here’s What Happened - Defense World
ChromaDex (NASDAQ:CDXC) Shares Pass Above 200-Day Moving AverageWhat's Next? - MarketBeat
ChromaDex Corp Partners with Persona Nutrition, Expanding Global Partnership with Nestlé Health Science - Marketscreener.com
ChromaDex to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025 - Business Wire
Barclays PLC Purchases 53,472 Shares of ChromaDex Co. (NASDAQ:CDXC) - Defense World
Geode Capital Management LLC Raises Holdings in ChromaDex Co. (NASDAQ:CDXC) - Defense World
ChromaDex (NASDAQ:CDXC) Downgraded to Buy Rating by StockNews.com - Defense World
ChromaDex (NASDAQ:CDXC) Stock Rating Lowered by StockNews.com - MarketBeat
Franklin Resources Inc. Takes Position in ChromaDex Co. (NASDAQ:CDXC) - Defense World
State Street Corp Purchases 62,692 Shares of ChromaDex Co. (NASDAQ:CDXC) - Defense World
ChromaDex (NASDAQ:CDXC) Shares Cross Above 200-Day Moving Average – Here’s What Happened - Defense World
ChromaDex (NASDAQ:CDXC) Share Price Passes Above Two Hundred Day Moving AverageHere's Why - MarketBeat
The Zacks Analyst Blog Highlights ADMA Biologics, Tarsus Pharmaceuticals, Stoke Therapeutics, Inc. and ChromaDex - Yahoo Finance
StockNews.com Upgrades ChromaDex (NASDAQ:CDXC) to “Strong-Buy” - Defense World
Fmr LLC Takes Position in ChromaDex Co. (NASDAQ:CDXC) - Defense World
ChromaDex (NASDAQ:CDXC) Stock Rating Upgraded by StockNews.com - MarketBeat
4 Drug, Biotech Stocks Rising More Than 50% In 2024 With Room To Grow - Barchart
4 Drug, Biotech Stocks Rising More Than 50% in 2024 With Room to Grow - Yahoo Finance
The Manufacturers Life Insurance Company Has $72,000 Position in ChromaDex Co. (NASDAQ:CDXC) - Defense World
ChromaDex (NASDAQ:CDXC) Lowered to Buy Rating by StockNews.com - Defense World
ChromaDex (NASDAQ:CDXC) Lowered to "Buy" Rating by StockNews.com - MarketBeat
ChromaDex appoints Crowe as new auditor - Investing.com
ChromaDex appoints Crowe as new auditor By Investing.com - Investing.com Canada
BNP Paribas Financial Markets Increases Position in ChromaDex Co. (NASDAQ:CDXC) - Defense World
Frank L. Jaksch, Jr. Sells 37,161 Shares of ChromaDex Co. (NASDAQ:CDXC) Stock - MarketBeat
Chromadex director Frank Jaksch sells $229,955 in stock - Investing.com
MetLife Investment Management LLC Acquires 5,115 Shares of ChromaDex Co. (NASDAQ:CDXC) - Defense World
Even though ChromaDex (NASDAQ:CDXC) has lost US$73m market cap in last 7 days, shareholders are still up 389% over 1 year - Yahoo Finance
ChromaDex (NASDAQ:CDXC) Upgraded by StockNews.com to Strong-Buy Rating - Defense World
ChromaDex (CDXC) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance
ChromaDex (NASDAQ:CDXC) Shares Gap UpTime to Buy? - MarketBeat
ChromaDex maintains Buy rating on recent agreement By Investing.com - Investing.com Canada
ChromaDex maintains Buy rating on recent agreement - Investing.com
ChromaDex Named to the Inc. 2024 Best in Business List in the Health Products Category - The Bakersfield Californian
Chromadex Corp Stock (CDXC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Chromadex Corp Stock (CDXC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Jaksch Frank L Jr | Director |
Dec 13 '24 |
Sale |
6.19 |
37,161 |
229,956 |
244,179 |
1.60%
2.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):